Hailemichael, Yohannes
Hailemariam, Damen
Tirfessa, Kebede
Docrat, Sumaiyah
Alem, Atalay
Medhin, Girmay
Lund, Crick
Chisholm, Dan
Fekadu, Abebaw
Hanlon, Charlotte
Funding for this research was provided by:
European Union's Seventh Framework (FP7/2007-2013)
Article History
Received: 10 August 2018
Accepted: 23 May 2019
First Online: 1 June 2019
Ethics approval and consent to participate
: Ethical approval was obtained from the Institutional Review Board (IRB) of the College of Health Sciences, Addis Ababa University (Reference number 074/13/Psy), King’s College London (KCL), and the Ethics Review Committee of the World Health Organization (RPC 619). Voluntary informed consent was obtained from all study participants prior to their inclusion in the study. Participants diagnosed as having SMD received health centre-based mental healthcare through PRIME.
: Not applicable.
: This study is part of a Ph.D. research and the source of the funding is partially from Addis Ababa University. We declare that we have no other competing interests.